Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans

Addiction

Volumn 107, Issue 4, 2012, Pages 783-791

  Kirkpatrick, Matthew G ^a,b,d   Gunderson, Erik W ^b   Johanson, Chris Ellyn ^c   Levin, Frances R ^b   Foltin, Richard W ^b   Hart, Carl L ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amphetamines; D amphetamine; Humans; Methamphetamine; Performance; Self administration; Subjective effects

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHAMPHETAMINE;

ADULT; AMBULATORY CARE; ARTICLE; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG SELF ADMINISTRATION; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; PSYCHOMOTOR DISORDER; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ADMINISTRATION, INTRANASAL; ADULT; AMBULATORY CARE; AMPHETAMINE-RELATED DISORDERS; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MALE; METHAMPHETAMINE; NEW YORK; PSYCHOMOTOR DISORDERS; SELF ADMINISTRATION;

EID: 84857566237     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03706.x     Document Type: Article

References (32)

1. Bartholow M. Top 200 prescription drugs of 2009. Pharm Times website 2010. Available at: Accessed 28 November 2011. (Archived at ).
2. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies. Treatment Episode Data Set (TEDS) highlights-2007 national admissions to substance abuse treatment services. OAS Series #S-45, HHS Publication no. (SMA) 09-4360. Rockville, MD: SAMHSA; 2009.
3. Gulaboski R., Cordeiro M. N., Milhazes N., Garrido J., Borges F., Jorge M. etal. Evaluation of the lipophilic properties of opioids, amphetamine-like drugs, and metabolites through electrochemical studies at the interface between two immiscible solutions. Anal Biochem 2007; 361: 236-43.
4. Nichols D. E. Medicinal chemistry and structure-activity relationships. In: Cho A. K., Segal D. S., editors. Amphetamine and its Analogs. San Diego, CA: Academic Press; 1994, p. 3-41.
5. Melega W. P., Williams A. E., Schmitz D. A., DiStefano E. W., Cho A. K. Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 1995; 274: 90-6.
6. Hall D. A., Stanis J. J., Marquez Avila H., Gulley J. M. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior. Psychopharmacology 2008; 195: 469-78.
7. Kuhn D. M., Appel J. B., Greenberg I. An analysis of some discriminative properties of d-amphetamine. Psychopharmacologia 1974; 39: 57-66.
8. Balster R. L., Schuster C. R. A comparison of d-amphetamine, l-amphetamine, and methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav 1973; 1: 67-71.
9. Yokel R. A., Pickens R. Self-administration of optical isomers of amphetamine and methylamphetamine by rats. J Pharmacol Exp Ther 1973; 187: 27-33.
10. Martin W. R., Sloan J. W., Sapira J. D., Jasinski D. R. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 1971; 12: 245-58.
11. Lamb R. J., Henningfield J. E. Human d-amphetamine drug discrimination: methamphetamine and hydromorphone. J Exp Anal Behav 1994; 61: 169-80.
12. Sevak R. J., Stoops W. W., Hays L. R., Rush C. R. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther 2009; 328: 1007-18.
13. Simon S. L., Richardson K., Dacey J., Glynn S., Domier C. P., Rawson R. A. etal. A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 2002; 21: 35-44.
14. de Wit H., Dudish S., Ambre J. Subjective and behavioral effects of diazepam depend on its rate of onset. Psychopharmacology 1993; 112: 324-30.
15. Hatsukami D. K., Fischman M. W. Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA 1996; 276: 1580-8.
16. Fischman M. W., Foltin R. W., Nestadt G., Pearlson G. D. Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther 1990; 253: 760-70.
17. Johanson C. E., Uhlenhuth E. H. Drug preference and mood in humans: d-amphetamine. Psychopharmacology 1980; 71: 275-9.
18. Nader M. A., Woolverton W. L. Effects of increasing response requirement on choice between cocaine and food in rhesus monkeys. Psychopharmacology 1992; 108: 295-300.
19. Campbell U. C., Carroll M. E. Reduction of drug self-administration by an alternative non-drug reinforcer in rhesus monkeys: magnitude and temporal effects. Psychopharmacology 2000; 147: 418-25.
20. Hatsukami D. K., Pentel P. R., Glass J., Nelson R., Brauer L. H., Crosby R. etal. Methodological issues in the administration of multiple doses of smoked cocaine-base in humans. Pharmacol Biochem Behav 1994; 47: 531-40.
21. Higgins S. T., Bickel W. K., Hughes J. R. Influence of an alternative reinforcer on human cocaine self-administration. Life Sci 1994; 55: 179-87.
22. Hart C. L., Gunderson E. W., Perez A., Kirkpatrick M. G., Thurmond A., Comer S. D. etal. Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology 2008; 33: 1847-55.
23. McLeod D. R., Griffiths R. R., Bigelow G. E., Yingling J. An automated version of the digit symbol substitution test (DSST). Behav Res Methods 1982; 14: 463-6.
24. Miller T. P., Taylor J. L., Tinklenberg J. R. A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics. Neuropsychobiology 1988; 19: 90-6.
25. Higgins S. T. The influence of alternative reinforcers on cocaine use and abuse: a brief review. Pharmacol Biochem Behav 1997; 57: 419-27.
26. Halkitis P. N., Green K. A., Mourgues P. Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: findings from Project BUMPS. J Urban Health 2005; 82: 18-25.
27. Kelly B. C., Parsons J. T., Wells B. E. Prevalence and predictors of club drug use among club-going young adults in New York City. J Urban Health 2006; 83: 884-95.
28. Hart C. L., Ward A. S., Haney M., Foltin R. W., Fischman M. W. Methamphetamine self-administration by humans. Psychopharmacology 2001; 157: 75-81.
29. Alessi S. M., Roll J. M., Reilly M. P., Johanson C. E. Establishment of a diazepam preference in human volunteers following a differential-conditioning history of placebo versus diazepam choice. Exp Clin Psychopharmacol 2002; 10: 77-83.
30. Kirk J. M., de Wit H. Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol Biochem Behav 1999; 63: 137-42.
31. Lile J. A., Babalonis S., Emurian C., Martin C. A., Wermeling D., Kelly T. H. Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects. J Clin Pharmacol 2011; 51: 888-98.
32. Perez A. Y., Kirkpatrick M. G., Gunderson E. W., Marrone G., Silver R., Foltin R. W. etal. Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend 2008; 94: 258-62.